The Future of CMS Compliance for Healthcare Brokers

The Centers for Medicare & Medicaid Services (CMS) plays a major role in defining the healthcare landscape in the United States. As the agency responsible for administering the nation's major healthcare programs, CMS sets the standards and regulations that ensure quality and efficiency in healthcare delivery. One area in which CMS regulation is particularly crucial [...]

By |2024-05-29T18:57:23+00:00May 29th, 2024|Blog|

Exploring Nano- and Micro-scale Drug Delivery Systems for CKD

Nanotechnology has emerged as a promising avenue in the realm of medical science, offering tailored solutions for complex health conditions like chronic kidney disease (CKD). CKD, a progressive condition characterized by the gradual loss of kidney function, presents significant challenges for treatment due to its multifaceted nature. Conventional therapies often fall short in delivering drugs [...]

By |2024-05-08T15:47:15+00:00May 8th, 2024|Blog|

What Do Proposed Macro Changes Signal For Brokers in 2024 and Beyond?

With Q1 2024 already nearly complete, the brokerage market remains focused on its projected growth to $628.3 billion by 2032. For now, however, brokers and their commissions have grappled with evolving trends and regulatory shifts. This fact is especially true of healthcare, where proposed regulations aim to address concerns regarding the influence of broker incentives [...]

By |2024-03-22T17:17:52+00:00March 22nd, 2024|Blog|